Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| 2017/0304480 |
WASTE GAS SCRUBBING TOWER A waste gas scrubbing tower includes a tower body unit, a filtration unit arranged in the tower body unit, a washing unit that introduces water from an... |
| 2017/0304479 |
HOLDER FOR DISINFECTION OF TONOMETER TIPS OR THE LIKE AND METHOD OF USE A holder device for holding a plurality of tonometer tips or the like during a disinfection procedure has a top wall, spaced rims extending downward from the... |
| 2017/0304478 |
DISINFECTANT WIPE DISPENSER A disinfectant wipe dispenser is provided comprising a container having first and second compartments, the first compartment being dimensioned to store a... |
| 2017/0304477 |
APPARATUS AND METHOD FOR DETECTING MOISTURE IN A VACUUM CHAMBER A method of sterilizing medical instruments using a vacuum chamber connected to reservoir by a valve in a closed state is disclosed that includes placing... |
| 2017/0304476 |
STERILIZATION DEVICE AND METHODS Embodiments of the present disclosure generally relate to devices and methods for sterilizing equipment. More particularly, one or more embodiments described... |
| 2017/0304475 |
AEROSOL DEVICE An aerosol device having a bowl with a bottom defining a drain, and a side wall extending from the bottom to a rim. A nozzle is disposed within the bowl. The... |
| 2017/0304474 |
ODOR REMOVAL ASSEMBLY An assembly for removing odors from items having a first container formed from a material that is at least partially ozone impervious and that defines a first... |
| 2017/0304473 |
UV Sterilization Of Container, Room, Space Or Defined Environment Provided herein are portable ultraviolet (UV) devices, systems, and methods of use and manufacturing same. Methods of use include methods for UV disinfection... |
| 2017/0304472 |
METHOD AND APPARATUS FOR STERILIZING AND DISINFECTING AIR AND SURFACES AND
PROTECTING A ZONE FROM EXTERNAL... This invention relates to a method, process and apparatus for disinfecting and sterilizing all types of surfaces contaminated with microorganisms and toxic... |
| 2017/0304471 |
ANTICANCER THERAPY A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a... |
| 2017/0304470 |
HSP90-TARGETED INFLAMMATION AND INFECTION IMAGING AND THERAPY The present invention provides new methods for inflammation and infection imaging and related medical applications thereof. In some embodiments, the present... |
| 2017/0304469 |
ANGIOPEP AND DERIVATIVES THEREOF FOR IMAGING AMYLOIDS The present application relates to the molecular labeling and in vivo imaging of amyloids. Specifically, the present application relates to a polypeptide-based... |
| 2017/0304468 |
UPAR TARGETING PEPTIDE FOR USE IN PEROPERATIVE OPTICAL IMAGING OF INVASIVE
CANCER There is provided a novel conjugate that binds to the cell surface receptor uPA (uPAR). The conjugate is based on a fluorescence-labeled peptide useful as a... |
| 2017/0304467 |
BLUE DYED CHLORHEXIDINE ANTIMICROBIAL COMPOSITION FOR SKIN DISINFECTION The present invention relates in general terms to an antimicrobial composition having chlorhexidine and a dye selected from ... |
| 2017/0304466 |
AAV-Based Gene Therapy The invention relates to the field of andeno-associated virus (AAV) based gene therapy, in particular to the use of a combination of recombinant AAV-transgene... |
| 2017/0304465 |
ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MYOCILIN (MYOC) GLAUCOMA Provided herein are methods for treating myocilin (MYOC) glaucoma using adeno-associated viral (AAV) vectors. In some aspects, the AAV vectors encode R-spondin... |
| 2017/0304464 |
REGULATABLE ADENO-ASSOCIATED VIRUS (AAV) VECTOR The present invention relates to regulatable adeno-associated virus (AAV) vectors as well as to their use in gene therapy. It further relates to corresponding... |
| 2017/0304463 |
REGENERATING FUNCTIONAL NEURONS FOR TREATMENT OF DISEASE AND INJURY IN THE
NERVOUS SYSTEM Methods for producing new neurons in the brain in vivo are provided according to aspects of the present invention which include introducing NeuroD1 into a... |
| 2017/0304462 |
ARTIFICIAL ANTIGEN-PRESENTING CELLS AND METHODS FOR PRODUCING AND USING
THE SAME Described herein are biomimetic Janus particles useful as artificial antigen presenting cells capable of activating T cells in vitro. "Bull's eye" ligand... |
| 2017/0304461 |
Process For The Conjugation Of A Peptide Or Protein With A Reagent
Comprising A Leaving Group Including A... The invention relates to novel conjugating reagents capable of reaction with at least one nucleophile present in a peptide or protein, which contain at least... |
| 2017/0304460 |
METHOD OF CONJUGATING A POLYPEPTIDE The present disclosure relates to a method of conjugating a compound of formula (I) ##STR00001## with a polypeptide comprising at least one thiol group and... |
| 2017/0304459 |
METHODS AND COMPOSITIONS FOR INHALATION DELIVERY OF CONJUGATED
OLIGONUCLEOTIDE The present invention provides an inhalable formulation comprising a ligand conjugated oligonucleotide and particles of a physiologically acceptable... |
| 2017/0304458 |
METHOD FOR PREPARING MICROCARRIERS, MICROCARRIERS, AND APPLICATION THEREOF Objects of the present invention are to provide a preparation method which makes it possible to obtain porous microcarriers having unique properties and a... |
| 2017/0304457 |
ARTIFICIALLY ENGINEERED PROTEIN HYDROGELS TO MIMIC NUCLEOPORIN SELECTIVE
GATING Disclosed are synthetic polypeptides modeled after NspI nucleoporin which are useful for forming hydrogels characterized by selective permeability. The... |
| 2017/0304456 |
FAST DISSOLVING PHARMACEUTICAL COMPOSITION The subject invention is directed to a pharmaceutical composition comprising an open matrix network carrying a pharmaceutically active ingredient, wherein the... |
| 2017/0304455 |
LONG-ACTING POLYMERIC DELIVERY SYSTEMS Compositions comprised of a delivery vehicle or delivery system and an active agent dispersed within the delivery vehicle or system, wherein the delivery... |
| 2017/0304454 |
HYDROGEL PRODRUG FOR TREATMENT Aspects of the invention described herein include a hydrogel prodrug and methods of making a hydrogel prodrug for drug delivery. Also contemplated are methods... |
| 2017/0304453 |
THIOL-ENE FUNCTIONALIZED HYDROGELS Disclosed herein are biodegradable hydrogel network containing covalently crosslinked bonds between oligomeric poly(thiol) compounds and oligomeric ... |
| 2017/0304452 |
EMULSION COMPOSITION, POWDERY MATTER AND PRODUCTION METHOD OF EMULSION
COMPOSITION An objet of the present invention is to provide an emulsion composition, a powdery matter and a production method of an emulsion composition, each enabling... |
| 2017/0304451 |
PARENTERAL COMPOSITIONS OF BENDAMUSTINE Described herein are parenteral compositions of bendamustine. More particularly, parenteral compositions of bendamustine are in the form of solution. |
| 2017/0304450 |
PARENTERAL COMPOSITIONS AND USES THEREOF The present invention relates to a parenteral composition comprising an antibiotic and a non-steroidal anti-inflammatory agent in solution in a particular... |
| 2017/0304449 |
NON-AQUEOUS PATCH Non-aqueous patches comprising lidocaine, which is not dissolved and is present in a crystalline state, have poor permeability to the skin. Therefore,... |
| 2017/0304448 |
CAROTENOID PARTICLES AND USES THEREOF This invention relates to the incorporation of bioactive cargo molecules into particles with carotenoids, such as lycopene. The incorporation of a cargo... |
| 2017/0304447 |
NANOTUBE TRANS-MEMBRANE CHANNELS MIMICKING BIOLOGICAL PORINS Provided herein is a nanopore structure, which in one aspect is a "carbon nanotube porin", that comprises a short nanotube with an associated lipid coating.... |
| 2017/0304446 |
Compositions and Methods for Inhibition of HAO1 (Hydroxyacid Oxidase 1
(Glycolate Oxidase)) Gene Expression The invention relates to RNAi agents, e.g. double-stranded RNAi agents, targeting the HAO1 gene, and method of using such RNAi agents to inhibit expression of... |
| 2017/0304445 |
METHOD OF FILLING A CONTAINER WITH NO HEADSPACE The present invention is directed to methods for filling a container wherein the filled container has no headspace. The present invention is further directed... |
| 2017/0304444 |
GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) ANTIBODIES
AND METHODS OF USE THEREOF The present invention comprises human monoclonal antibodies that bind to GITR (also known as glucocorticoid-induced tumor necrosis factor receptor). Binding of... |
| 2017/0304443 |
COMBINATION THERAPIES OF EGFR INHIBITORS Combination therapies are disclosed. The combination therapies can be used to treat or prevent cancerous conditions and/or disorders. |
| 2017/0304442 |
ANTIGEN BINDING PROTEINS THAT BIND WISP1 There is disclosed compositions and methods relating to or derived from anti-WISP1 antibodies. More specifically, there is disclosed fully human antibodies... |
| 2017/0304441 |
Combination of Anti-CD20 Antibody and PI3 Kinase Selective Inhibitor Highly effective combinations of a compound of formula A (a PI3K.delta. selective inhibitor) and anti-CD20 antibodies are provided herein for the treatment and... |
| 2017/0304440 |
Treatment Methods for Rheumatoid Arthritis The present invention provides methods for selecting treatment methods for rheumatoid arthritis based on an objective selection process (algorithm). The... |
| 2017/0304439 |
METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS The disclosure relates to novel regimens for treating psoriasis, which employ a therapeutically effective amount of an IL-17 antagonist, e.g., an IL-17 binding... |
| 2017/0304438 |
METHODS OF USING ANTI-CD79b IMMUNOCONJUGATES Provided herein are methods of treating B-cell proliferative disorders in particular Follicular Lymphoma and/or Diffuse Large B-Cell Lymphoma using ... |
| 2017/0304437 |
BISPECIFIC MOLECULES CAPABLE OF SPECIFICALLY BINDING TO BOTH CTLA-4 AND
CD40 The present disclosure relates to bispecific molecules that specifically bind to both CD40 and CTLA-4, and in particular to both human CD40 and human CTLA-4. |
| 2017/0304436 |
NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES
AND GRAFT REJECTION The present invention relates to a peptide comprising an epitope within the macrophage scavenger receptor B-I, a method of using the same, a nucleic acid... |
| 2017/0304434 |
Novel Adjuvant Compositions This invention relates to adjuvant formulations comprising various combinations of triterpenoids, sterols, immunomodulators, polymers, and Th2 stimulators;... |
| 2017/0304433 |
VACCINE COMPOSITIONS AND METHODS OF USE TO TREAT NEONATAL SUBJECTS The presently disclosed subject matter relates to the fields of pharmacology and medicine, and provides vaccine compositions and methods of use, particularly... |
| 2017/0304432 |
NUCLEIC ACIDS FOR TREATMENT OF PEANUT ALLERGIES Provided herein are DNA vaccines for the treatment of peanut allergies. The vaccines comprise the coding sequence for one or more peanut allergenic epitopes... |
| 2017/0304431 |
Vaccine for Use in Protecting a Pig Against Porcine Endemic Diarrhea Virus The invention pertains to a vaccine for use in protecting a pig against an infection with porcine endemic diarrhea virus (PEDV), the vaccine comprising... |
| 2017/0304430 |
VIRUS VECTOR, CELL, AND CONSTRUCT A virus vector contains a genome that is derived from a virus belonging to the family Paramyxoviridae, and has a gene encoding a modified H protein, a gene... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.